Morgan Stanley »

Redhill Biopharma shares owned by Morgan Stanley

Quarter-by-quarter ownership of Redhill Biopharma (RDHL) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Redhill Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Redhill Biopharma held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Redhill Biopharma by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $133 360 0.37
2024-03-31 $273 516 0.53
2023-12-31 $841 576 1.46
2023-09-30 $207 401 0.52
2023-06-30 $721 601 1.20

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Morgan Stanley

Top funds holding Redhill Biopharma

Two Sigma Securities
Morgan Stanley
IFP Advisors

View all funds holding Redhill Biopharma